Pharmaceutical giant Novo Nordisk and telehealth company Hims & Hers Health have reached an agreement to work together after their recent legal dispute. The partnership will allow weight-loss medications including Wegovy to be sold through the Hims platform.
Pharmaceutical company Novo Nordisk and telehealth platform Hims & Hers Health have reached an agreement to collaborate following a legal confrontation that emerged last month, according to Bloomberg News reporting on Friday.
The Danish drugmaker, which produces the popular weight-loss medication Wegovy, will now make its obesity treatments available through the Hims & Hers online health platform under the new partnership arrangement.
According to Bloomberg’s report, which cited an unnamed source with knowledge of the situation, both companies are preparing to publicly reveal their collaboration agreement as early as Monday.
The partnership marks a significant shift from the adversarial relationship that had developed between the two healthcare companies, transforming their recent legal conflict into a business alliance focused on expanding access to weight-loss treatments.
Minnesota Wild Make Two Trades, Adding Foligno Brothers and Bobby Brink
Dallas Stars Forward Hintz Exits Game Early With Leg Injury
Baseball Star’s Son Blasts Two Home Runs for Brazil in World Classic
South African Women Turn to Firearms and Self-Defense Training Amid Violence Crisis